Skip to main content
. 2014 Jul 8;14:491. doi: 10.1186/1471-2407-14-491

Table 3.

Local-regional progression-free survival in 120 stage IV NSCLC patients according to radiotherapy dose

Cycle Dose (Gy) No. Survival rate (%)
Median survival (months) 95% confidence interval χ 2 p
1 year 2 year 3 year 5 year
2-3
<63
23
41.7
27.8
20.9
0
10
5.5
14.5
0.040
0.842
≥63
23
43.5
26.1
19.6
0
9
4.3
13.7
4-5 <63
18
32.6
21.7
0
0
9
6.6
11.4
9.217 0.002
≥63 56 77.4 36.2 27.2 15.9 20 16.5 23.5